By Dr Florence MouyEdited by Dr Ahmed El-Medany A significant proportion of patients with heart failure are physically frail and these 2 conditions share similar…View More Heart failure and frailty phenotypes – A lesson from percutaneous mitral valve repair
By Dr Jonathan ShurlockEdited by Dr Ahmed El-Medany The TOMAHAWK Investigators, led by Dr Steffen Desch, have described clinical outcomes at 1 year for individuals…View More TOMAHAWK trial – clinical outcomes from 1-year follow-up
By Dr Jonathan ShurlockSenior Editor: Dr Saadia Aslam Healthcare systems around the world are in crisis, with increased demand, high burden of chronic disease, escalating…View More Overdiagnosis: a problem with complex solutions?
By Dr Jonathan ShurlockEdited by Dr Ahmed El-Medany This week, in a press release, the government announced that every state funded school in England has…View More Government announces defibrillators in all state funded schools
By Dr Jonathan ShurlockEdited by Dr Saadia Aslam Perioperative myocardial infarction is associated with increased mortality. The 2022 ESC guidelines have made a class I…View More Routine postoperative troponin monitoring… should we?
By Dr Jonathan ShurlockEdited by Dr Ahmed El-Medany The role of aspirin in primary prevention of cardiovascular disease has been explored previously, with resultant NICE…View More Revisiting the role of aspirin in primary prevention: there isn’t one
By Dr Jonathan ShurlockEdited by Dr Ahmed El-Medany A fascinating study in the BMJ has begun to unpick and explore the role of private equity…View More Association of private equity ownership on healthcare outcomes and costs
By Dr Jonathan ShurlockEdited by Dr Saadia Aslam The European-Endocarditis registry (Euro-Endo) presents current diagnostic and management practices for infective endocarditis (IE) and associated outcomes…View More Device extraction as standard of care for device related endocarditis
By Dr Jonathan ShurlockEdited by Dr Saadia Aslam Etripamil is a rapid-acting, intranasally administered calcium channel blocker. Previously, the NODE-301 study found it to be…View More The role of self-administered intranasal etripamil in the management of SVT: the RAPID trial
By Dr Jonathan ShurlockEdited by Dr Ahmed El-Medany In March we reported on the British Heart Foundation (BHF) response to NHS England’s figures demonstrating growing…View More Cardiac waiting lists continue to grow: Part II